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Passive immunization against Histomonas meleagridis does
not protect turkeys from an experimental infection
Nele Bleyen1*, Ellen Ons1, Maarten De Gussem2 and Bruno M. Goddeeris1
1Division Gene Technology, Department Biosystems, Faculty of Bioscience Engineering, K.U. Leuven, Kasteelpark
Arenberg 30, 3001 Leuven, Belgium, and 2Alpharma Animal Health Inc., Laarstraat 16, B-2610 Antwerpen, Belgium
Histomonosis or blackhead is a disease of gallinaceous birds, caused by the protozoan Histomonas
meleagridis. As recent regulatory action has removed almost all drugs against this disease from the European
market, the development of new prophylactics has become crucial. Identification of the protective immune
mechanism would facilitate the choice and development of a vaccination strategy to prevent histomonosis. In
this study, turkeys were either actively or passively immunized and were then challenged to assess the role of
antibody-mediated immunity in the protection from this disease. Active immunization was performed either
by experimental infection and treatment or by intramuscular injection with lysed H. meleagridis. Passive
immunization was attempted by intraperitoneal administration of pooled, concentrated, neutralizing
antisera from immunized donor animals to naı¨ve turkeys. A significantly higher IgG response was observed
after infection and treatment than after intramuscular injection, which in turn was higher than the responses
of placebo and control birds. While active immunization of turkeys by intramuscular injection of dead
H. meleagridis antigens appeared not to be protective against histomonosis, immunization by infection and
treatment did induce protection. However, no significant level of protection could be observed in the
passively immunized birds. These results suggest that serum antibodies to H. meleagridis may not be a key
component in the protection against this parasite. It is, however, possible that the concentration of
antibodies at the mucosal site is insufficient. Therefore, further investigation on mucosal immune responses
is necessary.
Introduction
Histomonosis or blackhead*a disease of gallinaceous
birds, especially of turkeys*is caused by the protozoan
parasite Histomonas meleagridis. The disease is charac-
terized by necrotic foci in the liver, thickening and
ulceration of the caecal wall and sulphur-coloured
droppings. Mortality and morbidity may reach 100%
in turkeys, while the disease is much less severe in
chickens (McDougald, 1991). Due to recent regulatory
action, a registered product for the prevention or
treatment of blackhead is no longer available in the
European Union. This has encouraged the search for
alternative products, such as a vaccine against H.
meleagridis.
In the past, it has been established that the parasite
causes higher mortality in young turkeys than in adults,
demonstrating the possibility of immunity against H.
meleagridis in the older birds (Tyzzer, 1934). However,
immunization by intramuscular or intravenous injections
with diseased tissue emulsions failed to induce protec-
tion against histomonosis (Higgins, 1915; Tyzzer et al.,
1921). Recently, intramuscular vaccination with inacti-
vated, cloned H. meleagridis was also unable to cause
protection (Hess et al., 2008). In contrast, attempts to
vaccinate turkeys with in vitro attenuated H. meleagridis
have led to partial or even complete protection (Tyzzer,
1933, 1934, 1936; Lund et al., 1966; Hess et al., 2008),
although the effector mechanisms of this protective
immunity remain unclear. In 1963, Clarkson investigated
the protective value of antibodies against this parasite.
He passively immunized naı¨ve birds with antisera
collected from infected and treated birds. His results
suggested that antibodies do not protect birds from
histomonosis, although only a semi-quantitative analysis
of the immune response was conducted and specific
antibody titres were not measured (Clarkson, 1963).
Hence, the objective of the present study was to
determine the strength and protective value of an
antibody response against H. meleagridis.
Materials and Methods
Turkeys and parasites. All animal experiments were approved by the
Ethical Committee for Animal Experiments of the K.U. Leuven,
according to the international regulations (project number P05098).
Commercial turkeys (breed BIG6) were obtained as 1-day-old poults
and housed on litter in a room with high efficiency particulate arresting
(HEPA)-filtered air. They had free access to food and water.
To immunize and challenge the turkeys, H. meleagridis strain mdc
(Bleyen et al., 2007) was cultured as described by McDougald &
Galloway (1973). Microscopic analysis and a diagnostic polymerase
*To whom correspondence should be addressed. Tel: 32 16 32 14 33. Fax: 32 16 32 19 94. E-mail: Nele.Bleyen@biw.kuleuven.be
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chain reaction (Bleyen et al., 2007) were performed to confirm the
presence of H. meleagridis.
Experiment 1: analysis of protection after active immunization. Thirty-
four turkeys were randomly divided into four groups. Two groups acted
as controls: an uninfected, non-immunized control (UNC, four birds)
and an infected, non-immunized control (INC, 10 birds). Two groups of
10 turkeys were immunized against H. meleagridis either by infection
and treatment (IC) or by intramuscular immunization with H.
meleagridis antigens (IM).
At 21 days of age (0 days post immunization [d.p.i.]), group IC was
infected via the cloaca with 2105 H. meleagridis protozoa, as
described by McDougald & Fuller (2005). Six days later, as clinical
signs were showing, the birds were treated with ronidazole 10 mg/kg
(Tricho Plus, Oropharma, Maastricht, The Netherlands). Also at 0
d.p.i., group IM was immunized intramuscularly with H. meleagridis
antigens. The antigens were prepared by homogenizing infected caeca
and foci of the liver in 0.9% NaCl solution (‘‘physiological saline’’) and
lysing the cells (2105 H. meleagridis/ml) by sonication. Protein
concentrations were determined with a protein assay using bicincho-
ninic acid for the colourimetric detection and quantitation. (Pierce,
Rockford, Illinois, USA). Each bird received 250 mg of protein,
emulsified in Freund’s incomplete adjuvant (Sigma, Steinheim, Ger-
many). Three weeks later (20 d.p.i.), a booster immunization was
administered to group IM in the same manner. Groups UNC and INC
were not treated during this period of the experiment.
At 27 d.p.i., groups INC, IC and IM and were challenged via the
cloaca with 105 H. meleagridis organisms. Ten days later (10 days post
challenge), all animals were killed by decapitation for postmortem
examination. Macroscopic liver lesions were scored as follows: 0
normal; 1a few small foci (off-white and variable in appearance)
visible on the surface of the liver; 2lesions covering one-half of the
liver surface; 3necrotic lesions (often large) covering more than 50%
of the liver surface; and 4death from histomonosis, with coalescing,
necrotic lesions all over the liver surface. Lesions in the caeca were
scored as follows: 0normal; 1a few scattered small lesions, but little
or no thickening of the mucosal wall; 2yellow and foamy contents,
lesions prominent but discreet and some bleeding and thickening of the
mucosa visible; 3enlarged caeca, empty or filled with yellow caseous
abnormal lumen contents, thickened walls and confluent lesions, entire
caecum involved; and 4death from histomonosis, distended caeca with
fragile walls and necrotic lesions.
Experiment 2: specific antibody response to active immunization. For the
generation of immune serum, 49 turkeys were divided randomly into
five groups. At 24 days of age, two groups*group HIC (10 birds) and
*group HIM (10 birds)*received the same treatment as the IC and IM
groups, respectively (see Experiment 1). A placebo group was inoculated
via the cloaca with homogenized caeca and liver from an uninfected
turkey (PIC, 10 turkeys), and another group was immunized intramus-
cularly (PIM, nine turkeys) with the same mixture. At 20 d.p.i., a
booster immunization was administered to all groups in the same
manner. The control group (CON, 10 turkeys) was neither vaccinated
nor challenged. Blood samples were taken at 0, 6, 13, 20 and 27 d.p.i. (at
necropsy). Serum was collected and stored at 208C for indirect
immunofluorescence assays (IFA). Seven days after the booster was
given (27 dpi), the birds were killed by decapitation, all blood was
collected and necropsy was performed. Antiserum collected from each
group (HIC, HIM, PIC and PIM) was pooled and used for antibody
transfer to naı¨ve turkeys (Experiment 3, see below).
To determine serum IgG titres by IFA, 25 ml of a 2-day-old culture of
H. meleagridis (5105/ml) fixed in 4% paraformaldehyde were seeded
onto the 6 mm wells of a Teflon-coated slide (Immuno-Cell, Mechelen,
Belgium). They were air-dried and treated with blocking buffer (5%
horse serum, 0.02% sodium azide in phosphate-buffered saline) for 30
min at 378C. The slides were then incubated with two-fold dilutions of
the test sera (in blocking buffer) for 30 min at 378C. Finally, the slides
were incubated with goat fluorescein isothyocyanate-labelled anti-
turkey (IgG) antibodies (1/50 diluted in blocking buffer; KPL, Mary-
land, USA) for 30 min at 378C. Fluorescence staining was examined
microscopically at 500 magnification.
Experiment 3: analysis of protection after passive immunization. Anti-
bodies from the pooled sera from Experiment 2 were precipitated in
ammonium sulphate (40% wt./vol.) and the pellets were resuspended in
1/10 volume physiological saline. The antibody mixtures were subse-
quently dialysed extensively against physiological saline. Antibody titres
were determined by IFA as described above.
Before antibody transfer, the pooled and concentrated antisera were
evaluated for their ability to induce complement-mediated lysis of H.
meleagridis. A 2-day-old culture was diluted in culture medium to a
concentration of approximately 1.5105 H. meleagridis/ml. Serum
collected from a H. meleagridis-negative turkey (confirmed by IFA) was
used as the source of complement. Pooled antisera from the HIC and
the HIM groups were tested, while that from the CON group was used
as a control. Prior to use, these test samples were inactivated at 568C for
30 min. The assay was performed in a sterile 96-well Cellstar culture
plate (Greiner Bio-One, Wemmel, Belgium).
Each test reaction contained 50 ml H. meleagridis culture, 50 ml tested
antisera (undiluted, and 1/10, 1/100 and 1/1000 diluted) and 50 ml
complement. Control reactions included parasites plus complement
(PC) and parasites plus physiological saline (PP). The concentration of
parasites in each reaction mixture was determined, using a Neubauer
counting chamber, at the beginning of the experiment, after incubation
at 378C for 1 h, for 3 h and after overnight incubation. The percentage
reduction in live parasites was calculated as follows:
% reduction[(concentrationstart
concentrationx hours after incubation)=concentrationstart]100:
For the passive immunization, 35 turkeys were divided in six groups
(see later Table 3). At 5 weeks of age, the birds were given an
intraperitoneal injection of 4 ml concentrated antisera. The passively
immunized groups, PASHIC and PASHIM, received antibodies from
the HIC and HIM groups, respectively; while the placebo groups
PASPIC and PASPIM received concentrated PIC and PIM antibodies,
respectively. Groups POS and NEG were not immunized. Four hours
after serum transfer, the birds in all groups except for the NEG group
were challenged via the cloaca with 3105 H. meleagridis. Ten days
later (10 days post transfer), all of the turkeys were killed by
decapitation for postmortem examination of livers and caeca as
described above. To track the antibody titres before and after passive
immunization, blood was taken 1 day before (1 day post transfer), 1
day after serum transfer and at 10 days post transfer. Sera were
collected and stored at 208C until analysis by IFA as described above.
Statistical analysis. All statistical analyses were performed using the
SAS 8.2 software (SAS Institute, Cary, North Carolina, USA). Lesion
scores, antibody titres in the sera at each time point and mortality rates
were compared using KruskalWallis analysis to detect significant
differences between multiple groups, and the Wilcoxon rank sum test
was used to compare differences between each pair of groups. P50.05
was considered to be significant.
Results
Experiment 1: analysis of protection after active
immunization. During immunization by infection and
treatment, two birds of the IC group died of histomo-
nosis (at 8 d.p.i. and 21 d.p.i.). After challenge, none of
the immunized birds of the IC group and only one bird
of the intramuscularly immunized IM group died (8 days
post challenge). Six birds of the infected, non-immunized
control INC group died of histomonosis, three at 9 days
post challenge and three at 10 days post challenge. There
were no significant differences between the mortality
rates of the uninfected UNC group and those of the
immunized and challenged IC and IM groups, while the
mortality of the challenged but non-immunized
INC group differed significantly from all other groups
(Table 1).
In the liver, significant differences were seen between
the mean lesion scores of the non-immunized INC group
72 N. Bleyen et al.
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and the IC and UNC groups and between the IM group
and the IC and UNC groups. No significant differences
were observed between mean liver lesion scores of the
INC and the IM group, or between the IC and the
uninfected control UNC group. The mean caecal lesion
score of the IC group was significantly lower than those
of the INC and IM groups, but significantly higher than
that of the UNC group. There were no statistical
differences between the mean caecal lesion scores of
the IM and INC groups, which were both significantly
higher than those of the UNC and the IC groups. The
mean caecal lesion scores of the surviving birds of the
INC and the IM groups were however 1 and 2,
respectively, while their mean liver lesions were 1.25
and 2, respectively (Table 1).
Experiment 2: specific antibody response to active
immunization. Analysis of the serum IgG response
against H. meleagridis using IFA with fixed H. melea-
gridis as antigen showed that the parasites fluoresced
intensely. Without primary incubation with antisera, no
fluorescence could be detected, indicating the absence of
autofluorescence or non-specific fluorescence.
The mean anti-H. meleagridis antibody titres of the
immunized groups (HIC and HIM) were significantly
higher than those of the placebo (PIC and PIM) and
control (CON) groups, from 6 d.p.i. (HIC) and from 13
d.p.i. (HIM) onwards (Figure 1). From 6 d.p.i., sig-
nificantly higher anti-H. meleagridis antibody titres were
found in group HIC compared with group HIM*except
for 13 d.p.i., when no significant differences could be
detected between them. Throughout the entire experi-
ment, no significant differences were observed between
the placebo and the control groups.
Experiment 3: analysis of protection after passive
immunization. Before antibody transfer, the pooled,
concentrated antisera were evaluated for their bioactivity
by examining their ability to induce complement-
mediated lysis of H. meleagridis. The results of this test
are presented in Table 2. Incubation of H. meleagridis
with complement and the undiluted HIC or HIM
concentrated serum pools resulted in a reduction in
living parasites after 1 h. Moreover, after 3 h and after
overnight incubation, growth of H. meleagridis was
impeded by 100% in both samples. This reduction was
detectable at serum dilutions of 1/10 and 1/100 but not at
1/1000. When incubating the parasites and the comple-
ment with the pooled CON sera or without test sera, no
reduction and even growth (indicated in Table 2 by the
negative values) could be observed.
The anti-H. meleagridis antibody titres as determined
by IFA are shown in Figure 2. One day before passive
serum transfer (1 day post transfer), no statistical
differences in antibody titres could be detected. One day
after transfer (1 day post transfer), the titres of the
passively immunized groups (PASHIC and PASHIM)
increased respectively 9.8-fold and 7.5-fold compared
with the titres at 1 day post transfer, and were
significantly different from the titres of the other groups.
The birds were challenged via the cloaca 4 h after passive
serum transfer. On the day of necropsy (10 days post
transfer), the titres of groups PASHIC and PASHIM
were still significantly different from those from groups
PASPIC, PASPIM and POS. The antibody titres from all
challenged groups were significantly different from
group NEG at 10 days post transfer.
Table 1. Experiment 1: mortality and mean lesion scores of groups of turkeys after active immunization and challenge with H. meleagridis
Mean lesion scorese
Groupa Totalb Immunization Challengec Mortality (%)d Caeca Liver
UNC 4   0A 0.0A 0.0A
INC 10   60B 2.8B 2.9B
IC 8 Infection/treatment  0A 1.1C 0.1A
IM 10 intramuscular  10A 2.2B 2.2B
Different uppercase superscript letters (within a column) indicate a statistical difference (P50.05). aUNC, uninfected, non-
immunized control; INC, infected, non-immunized control; IC, immunized by infection and treatment; IM, immunized by
intramuscular injection with H. meleagridis antigens. bNumber of turkeys in each group on the day of challenge. cEach group, except
for the UNC group, was challenged with 105 H. meleagridis. dMortality by 10 days post challenge: three INC birds died 9 days post
challenge, three died 10 days post challenge; one IM bird died 8 days post challenge. eMean lesion scores on the day of autopsy. Birds
that died of histomonosis were given a lesion score of 4 per organ.
0 dpi 6 dpi 13 dpi 20 dpi 27 dpi
m
ea
n
 a
n
ti 
H
. m
el
ea
gr
id
is 
Ig
G
 ti
tre
s (
log
2)
4
6
8
10
12
HIC
HIM
PIC
PIM
CON
a
b
bc
c
bc
a
a
b
b
b
a
b
c
c
c
a
b
c c c
*
Figure 1. Experiment 2: serum antibody responses of groups of
turkeys after active immunization with H. meleagridis. Turkeys
immunized at 0 d.p.i., with a booster at 20 d.p.i. (indicated by
the asterisk). HIC, immunized by intracloacal infection with
H. meleagridis; HIM, immunized intramuscularly with H.
meleagridis antigens; PIC, immunized by intracloacal injection
with H. meleagridis-negative liver and caecal homogenate; PIM,
immunized as PIC but intramuscularly; CON, non-immunized
control. Titres measured by indirect immunofluorescence. Differ-
ent lowercase letters indicate significant differences between
treatments at each time point.
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All challenged groups showed lesions in the examined
organs (Table 3), but no significant differences between
the mean lesion scores of the challenged groups could be
found. For the unchallenged NEG group, no lesions
could be detected in the liver or caeca, resulting in a
significant difference in mean lesion scores between this
group and the challenged groups.
Discussion
In the present study, an anti-H. meleagridis serum
antibody response was detected after immunization by
infection and treatment and after intramuscular immu-
nization with H. meleagridis antigens. Immunity induced
by intramuscular injection of dead H. meleagridis
antigens appeared not to be protective against histomo-
nosis. In contrast, turkeys actively immunized by infec-
tion followed by treatment were protected against a H.
meleagridis challenge. However, transfer of anti-H.
meleagridis antibodies to naı¨ve turkeys did not protect
them against challenge via the cloaca with 3105 H.
meleagridis organisms.
Several earlier studies encouraged us to investigate the
protective value of the serum antibodies against H.
meleagridis. Tyzzer (1934) suggested that protective
immunity could be age-related, as older birds are more
likely to be immune to this disease. Furthermore, a
degree of protection against intracloacal challenge with
H. meleagridis and against an oral challenge with H.
meleagridis-contaminated Heterakis gallinarum eggs was
detected after young turkeys were vaccinated with
attenuated cultures of H. meleagridis (Tyzzer, 1933,
1934, 1936; Lund et al., 1966). Recently, cloned attenu-
ated H. meleagridis has been shown to induce protection
against an intracloacal challenge (Hess et al., 2008).
However, examination of the immune response was not
included in these studies so it was not possible to link
this protection to a systemic or mucosal immune
response.
In 1963 Clarkson performed a passive immunization
experiment to determine whether antibodies could
protect turkeys against H. meleagridis, and suggested
that they could not or could not completely induce
protection. However, he used only a semi-quantitative
analysis of the immune response (Clarkson, 1963),
Table 2. Lytic activity of anti-H. meleagridis antibodies after different incubation times
Reduction in growth of H. meleagridis by serum antibodies after incubation (%)a
Sampleb 1 h 3 h Overnight
HIC
Undiluted 88 100 100
1/10 75 50 50
1/100 75 0 50
1/1000 33 67 67
HIM
Undiluted 67 100 100
1/10 50 38 25
1/100 50 50 50
1/1000 50 50 100
CON
Undiluted 0 0 100
1/10 43 43 186
1/100 43 43 114
1/1000 0 0 150
Controls
PCc 71 71 186
PPd 40 100 200
a% reduction[(concentrationstart  concentrationx hours after incubation)/concentrationstart]100. A negative value indicates growth, a
positive value indicates reduction. bReaction containing parasites, complement and (un)diluted test sera from HIC, HIM or CON
groups. HIC, immunized by intracloacal infection with H. meleagridis; HIM, immunized intramuscularly with H. meleagridis
antigens; CON, non-immunized control group. cControl reaction containing parasites and complement. dControl reaction containing
only parasites.
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Figure 2. Experiment 3: serum antibody responses of groups of
turkeys after passive immunization and challenge with H.
meleagridis. *Transfer of immune serum and challenge (4 h
later) with H. meleagridis at 0 days post transfer (dpt).
PASHIC, passively immunized with HIC antibodies; PASHIM,
passively immunized with HIM antibodies; PASPIC, received
antibodies from PIC; PASPIM, received antibodies from PIM;
POS, non-immunized challenged group; NEG, non-immunized
non-challenged group. Titres measured by indirect immunofluor-
escence. Different lowercase letters indicate significant differ-
ences between treatments at each time point.
74 N. Bleyen et al.
D
o
w
n
lo
ad
ed
 B
y:
 [
Un
iv
er
si
te
it
 G
en
t]
 A
t:
 1
0:
33
 2
3 
Ma
rc
h 
20
09
whereas in the present study actively and passively
immunized and challenged turkeys were examined on a
quantitative basis, to determine the protective value of
antibodies against this parasite.
In Experiment 1, the degree of protection was
analysed after actively immunizing turkeys. Following
challenge of turkeys immunized by infection and treat-
ment (IC group), the caeca of the birds showed signs of
infection, although the parasites did not appear to
migrate to the liver or cause death. This clearly showed
that turkeys are protected against H. meleagridis after
infection and treatment. A second group of birds (group
IM) was immunized by intramuscular injection with
dead H. meleagridis antigens derived from infected livers
and caeca. This choice of immunizing material should
generate antibodies against all in vivo stages as the
parasite appears in different stages within its host (Lee
et al., 1969; Honigberg & Bennett, 1971) but it resulted
in significantly higher mean lesion scores of both the
liver and caeca than those of the IC and the negative
control group*although, as far as we could judge the
mortality at 10 days post challenge, only one of 10 birds
died of histomonosis. Furthermore, the mean lesion
scores of the surviving birds were higher in the IM group
than in the INC (infected non-immunized control)
group, suggesting that immunity induced by dead
antigens is not protective against histomonosis. These
findings are supported by the results of Hess et al.
(2008).
In a second active immunization experiment (Experi-
ment 2) a strong anti-H. meleagridis serum antibody
response was produced after experimental infection and
recovery, while intramuscular immunization resulted in a
slightly lower, but still significant, antibody response.
The booster immunization resulted in both groups in a
subsequent significant increase in parasite-specific serum
antibodies.
In the passive immunization Experiment 3, the sera
from the second experiment were concentrated and
transferred to naı¨ve animals. After transfer, the titres
of the anti-H. meleagridis immunized groups (PASHIC
and PASHIM) increased respectively 9.8-fold and 7.5-
fold, resulting in higher mean antibody titres than those
of the originating groups (HIC and HIM). However,
despite the successful transfer of anti-H. meleagridis
antibodies, no protective effect was observed, at least not
against an intracloacal challenge with 3105 parasites.
It is possible that the antibody titres of the concen-
trated pooled sera for passive immunization were not
high enough to result in protection. This is considered
unlikely because group IC of Experiment 1 was pro-
tected after being immunized in the same manner as the
HIC group (Experiment 2), although these birds had
lower antibody titres at the day of challenge than the
titres after passive immunization. In vitro analysis of the
bioactivity of the specific antisera showed that the
antibodies transferred to the naı¨ve animals could still
activate the lysis of H. meleagridis but this activity
decreased at a dilution of 1/100 and ceased at 1/1000,
which could indicate that the anti-H. meleagridis activity
of the antibodies was not strong enough to induce
protection.
Another consideration is that the serum antibody
titres of passively immunized groups might no longer
have been high enough to be protective when the
infection reached its systemic phase. Indeed, the trans-
ferred antibodies peaked in the serum approximately 1
day after injection (preliminary experiment; data not
shown) and declined thereafter. However, the titres of
the passively immunized groups remained readily detect-
able and significantly higher than those of the placebo
groups. Thus, a certain level of protection should have
been seen.
Lastly, and most importantly, the challenge dose
might have been too high to simulate a natural challenge.
A lower challenge dose might have generated differences
in mean lesion scores, thus revealing the protective value
of the transferred antibodies.
Despite these explanations, the most logical and direct
conclusion of our study is that systemic immunity by
serum antibodies against H. meleagridis is not, or is not
primarily, responsible for protection against histomono-
sis. Instead, mucosal immune responses might be more
important in the prevention of this disease and deserve
further investigation.
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Table 3. Experiment 3: passive immunization and challenge against H. meleagridis
Mean lesion scorese
Group Totala Antibodiesb Challengec Deathsd Caeca Liver
PASHIC 5 HIC  0 3.0A 2.8A
PASHIM 6 HIM  1 3.0A 2.3A
PASPIC 5 PIC  0 2.7A 2.2A
PASPIM 6 PIM  0 2.8A 2.3A
POS 5 /  0 3.0A 2.5A
NEG 8 /  0 0.0B 0.0B
Different uppercase superscript letters (within a column) indicate a statistical difference (P50.05). aNumber of turkeys in each group.
bGroup from Experiment 2 providing the antibodies. cEach group, except for NEG, was challenged with 3105 H. meleagridis.
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